Use of medical face masks versus particulate respirators as a component of personal protective equipment for health care workers in the context of the COVID-19 pandemic
Currently available evidence supports that the predominant route of human-to-human transmission of the SARS-CoV-2 is through respiratory droplets and/or contact routes. The report by the World Health Organization (WHO) Joint Mission on Coronavirus Disease 2019 (COVID-19) in China supports person-to-person droplet and fomite transmission during close unprotected contact with the vast majority of the investigated infection clusters occurring within families, with a household secondary attack rate varying between 3 and 10%, a finding that is not consistent with airborne transmission. The reproduction number (R0) for the SARS-CoV-2 is estimated to be between 2.2-2.7, compatible with other respiratory viruses associated with a droplet/contact mode of transmission and very different than an airborne virus like measles with a R0 widely cited to be between 12 and 18. Based on the scientific evidence accumulated to date, our view is that SARS-CoV-2 is not spread by the airborne route to any significant extent and the use of particulate respirators offers no advantage over medical masks as a component of personal protective equipment for the routine care of patients with COVID-19 in the health care setting. Moreover, prolonged use of particulate respirators may result in unintended harms. In conjunction with appropriate hand hygiene, personal protective equipment (PPE) used by health care workers caring for patients with COVID-19 must be used with attention to detail and precision of execution to prevent lapses in adherence and active failures in the donning and doffing of the PPE.
| Errataetall: |
ErratumIn: Antimicrob Resist Infect Control. 2020 Sep 9;9(1):151. - PMID 32900385 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Antimicrobial resistance and infection control - 9(2020), 1 vom: 06. Aug., Seite 126 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Conly, John [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Airborne |
|---|
| Anmerkungen: |
Date Completed 26.08.2020 Date Revised 11.11.2023 published: Electronic ErratumIn: Antimicrob Resist Infect Control. 2020 Sep 9;9(1):151. - PMID 32900385 Citation Status MEDLINE |
|---|
| doi: |
10.1186/s13756-020-00779-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313378061 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313378061 | ||
| 003 | DE-627 | ||
| 005 | 20231225150438.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13756-020-00779-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1044.xml |
| 035 | |a (DE-627)NLM313378061 | ||
| 035 | |a (NLM)32762735 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Conly, John |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Use of medical face masks versus particulate respirators as a component of personal protective equipment for health care workers in the context of the COVID-19 pandemic |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.08.2020 | ||
| 500 | |a Date Revised 11.11.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ErratumIn: Antimicrob Resist Infect Control. 2020 Sep 9;9(1):151. - PMID 32900385 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Currently available evidence supports that the predominant route of human-to-human transmission of the SARS-CoV-2 is through respiratory droplets and/or contact routes. The report by the World Health Organization (WHO) Joint Mission on Coronavirus Disease 2019 (COVID-19) in China supports person-to-person droplet and fomite transmission during close unprotected contact with the vast majority of the investigated infection clusters occurring within families, with a household secondary attack rate varying between 3 and 10%, a finding that is not consistent with airborne transmission. The reproduction number (R0) for the SARS-CoV-2 is estimated to be between 2.2-2.7, compatible with other respiratory viruses associated with a droplet/contact mode of transmission and very different than an airborne virus like measles with a R0 widely cited to be between 12 and 18. Based on the scientific evidence accumulated to date, our view is that SARS-CoV-2 is not spread by the airborne route to any significant extent and the use of particulate respirators offers no advantage over medical masks as a component of personal protective equipment for the routine care of patients with COVID-19 in the health care setting. Moreover, prolonged use of particulate respirators may result in unintended harms. In conjunction with appropriate hand hygiene, personal protective equipment (PPE) used by health care workers caring for patients with COVID-19 must be used with attention to detail and precision of execution to prevent lapses in adherence and active failures in the donning and doffing of the PPE | ||
| 650 | 4 | |a Comparative Study | |
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Airborne | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Contact | |
| 650 | 4 | |a Droplet | |
| 650 | 4 | |a Infection prevention | |
| 650 | 4 | |a Medical mask | |
| 650 | 4 | |a N95 respirator | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Transmission | |
| 700 | 1 | |a Seto, W H |e verfasserin |4 aut | |
| 700 | 1 | |a Pittet, Didier |e verfasserin |4 aut | |
| 700 | 1 | |a Holmes, Alison |e verfasserin |4 aut | |
| 700 | 1 | |a Chu, May |e verfasserin |4 aut | |
| 700 | 1 | |a Hunter, Paul R |e verfasserin |4 aut | |
| 700 | 0 | |a WHO Infection Prevention and Control Research and Development Expert Group for COVID-19 |e verfasserin |4 aut | |
| 700 | 1 | |a Conly, John |e investigator |4 oth | |
| 700 | 1 | |a Cookson, Barry |e investigator |4 oth | |
| 700 | 1 | |a Pittet, Didier |e investigator |4 oth | |
| 700 | 1 | |a Holmes, Alison |e investigator |4 oth | |
| 700 | 1 | |a Chu, May |e investigator |4 oth | |
| 700 | 1 | |a Voss, Andreas |e investigator |4 oth | |
| 700 | 1 | |a Levin, Anna Sara Shafferman |e investigator |4 oth | |
| 700 | 1 | |a Seto, Wing Hong |e investigator |4 oth | |
| 700 | 1 | |a Kalisvar, Marimuthu |e investigator |4 oth | |
| 700 | 1 | |a Fisher, Dale |e investigator |4 oth | |
| 700 | 1 | |a Gobat, Nina |e investigator |4 oth | |
| 700 | 1 | |a Hunter, Paul R |e investigator |4 oth | |
| 700 | 1 | |a Sobsey, Mark |e investigator |4 oth | |
| 700 | 1 | |a Schwaber, Mitchell J |e investigator |4 oth | |
| 700 | 1 | |a Tomczyk, Sara |e investigator |4 oth | |
| 700 | 1 | |a Ling, Moi Lin |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Antimicrobial resistance and infection control |d 2012 |g 9(2020), 1 vom: 06. Aug., Seite 126 |w (DE-627)NLM220841640 |x 2047-2994 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2020 |g number:1 |g day:06 |g month:08 |g pages:126 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s13756-020-00779-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2020 |e 1 |b 06 |c 08 |h 126 | ||